APA (7th ed.) Citation

Long, J., Yang, X., Bian, J., Wang, D., Wang, A., Lin, Y., . . . Zhao, H. (2021). Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy. Clinical & Translational Medicine, 11(11), 1. https://doi.org/10.1002/ctm2.598

Chicago Style (17th ed.) Citation

Long, Junyu, et al. "Identification of TMB, CD8 T‐cell Abundance, and Homologous Repair Pathway Mutation Frequency as Predictors of the Benefit–toxicity Ratio of Anti‐PD‐1/PD‐L1 Therapy." Clinical & Translational Medicine 11, no. 11 (2021): 1. https://doi.org/10.1002/ctm2.598.

MLA (9th ed.) Citation

Long, Junyu, et al. "Identification of TMB, CD8 T‐cell Abundance, and Homologous Repair Pathway Mutation Frequency as Predictors of the Benefit–toxicity Ratio of Anti‐PD‐1/PD‐L1 Therapy." Clinical & Translational Medicine, vol. 11, no. 11, 2021, p. 1, https://doi.org/10.1002/ctm2.598.